(IEEE Spectrum) – Flow’s headset is the first tDCS device approved by the FDA

In December the FDA approved a tDCS headset produced by Flow Neuroscience for treatment of major depressive disorder. The decision paves the way for the Swedish company to make its device available in the United States via prescription, and millions of people may now have access through traditional health care to a noninvasive, nondrug treatment option for depression that can be self-administered in the home. (Read More)